Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03618654 · COMPLETED
Trial details
- NCT number
- NCT03618654
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2021-11-20
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.